Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi, SA Mousavi… - … and Apheresis Science, 2020 - Elsevier
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …
被引用次数：51 相关文章
[HTML] nih.gov

[HTML][HTML] Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi… - Transfusion and …, 2020 - ncbi.nlm.nih.gov
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi… - … and Apheresis Science, 2020 - trasci.com
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy.

S Balagholi, R Dabbaghi, P Eshghi… - … : Official Journal of the …, 2020 - europepmc.org
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …